Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TNYA

+ Watchlist+ Portfolio

Tenaya Therapeutics, Inc.

Regulated industryDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.32
52-Week Range
$0.30 – $1.46
Market Cap
$69.95M
P/E (TTM)
—
EPS (TTM)
-0.48
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.28
PEG Ratio
—
Return on Equity
-148.16%
Return on Assets
-55.43%
Gross Margin
100.00%
Operating Margin
-2656.89%
Profit Margin
0.00%
Current Ratio
3.78
Debt/Equity
0.05
Total Debt
$2.85M
Free Cash Flow
$-29.77M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$6.01M

Market Snapshot

About

Tenaya Therapeutics is a biotechnology company focused on discovering, developing, and delivering curative therapies for heart disease. The company utilizes three distinct therapeutic platforms: gene therapy, cellular regeneration, and precision medicine approaches to address genetic and non-genetic forms of heart failure. Tenaya aims to transform the treatment landscape for patients with serious cardiovascular conditions.